UG1A1 is involved in the metabolism of estrogen and several other drugs through glucuronidation. Hence, individuals with Gilbert syndrome may be susceptible to toxicities from medications that require glucuronidation. Irinotecan is well-known to cause toxicity in patients with Gilbert syndrome.